{"count": 48, "results": [{"_id": "37143189", "pmid": 37143189, "pmcid": "PMC10281183", "title": "Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer", "journal": "Am J Clin Oncol", "authors": ["Cao Z", "Yao J", "He Y", "Lou D", "Huang J", "Zhang Y", "Chen M", "Zhou Z", "Zhou X"], "date": "2023-07-01T00:00:00Z", "doi": "10.1097/COC.0000000000001012", "meta_date_publication": "2023 Jul 1", "meta_volume": "46", "meta_issue": "7", "meta_pages": "323-334", "score": 50278.062, "text_hl": "Subgroup analysis showed that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (OR=0.83, 95% CI=0.71-0.97, P=0.016) effectively reduced the incidence of @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@PCA@@@. ", "citations": {"NLM": "Cao Z, Yao J, He Y, Lou D, Huang J, Zhang Y, Chen M, Zhou Z, Zhou X. Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer Am J Clin Oncol. 2023 Jul 1;46(7):323-334. PMID: 37143189", "BibTeX": "@article{37143189, title={Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer}, author={Cao Z and Yao J and He Y and Lou D and Huang J and Zhang Y and Chen M and Zhou Z and Zhou X}, journal={Am J Clin Oncol}, volume={46}, number={7}, pages={323-334}}"}}, {"_id": "36672537", "pmid": 36672537, "pmcid": "PMC9855777", "title": "Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells", "journal": "Biomedicines", "authors": ["Kafka M", "Gruber R", "Neuwirt H", "Ladurner M", "Eder IE"], "date": "2022-12-22T00:00:00Z", "doi": "10.3390/biomedicines11010029", "meta_date_publication": "2022 Dec 22", "meta_volume": "11", "meta_issue": "1", "meta_pages": "", "score": 50272.65, "text_hl": "Long-Term Treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Leads to Reduced Migration Capacity of @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@Prostate Cancer@@@ Cells", "citations": {"NLM": "Kafka M, Gruber R, Neuwirt H, Ladurner M, Eder IE. Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells Biomedicines. 2022 Dec 22;11(1):. PMID: 36672537", "BibTeX": "@article{36672537, title={Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells}, author={Kafka M and Gruber R and Neuwirt H and Ladurner M and Eder IE}, journal={Biomedicines}, volume={11}, number={1}}"}}, {"_id": "38030198", "pmid": 38030198, "title": "Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells.", "journal": "Anticancer Res", "authors": ["Miyazawa Y", "Sekine Y", "Oka D", "Nakazawa S", "Tsuji Y", "Nakayama H", "Suzuki K"], "date": "2023-12-01T00:00:00Z", "doi": "10.21873/anticanres.16741", "meta_date_publication": "2023 Dec", "meta_volume": "43", "meta_issue": "12", "meta_pages": "5377-5386", "score": 50268.65, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Induces Autophagy and Inhibits Proliferation in @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@Prostate Cancer@@@ Cells.", "citations": {"NLM": "Miyazawa Y, Sekine Y, Oka D, Nakazawa S, Tsuji Y, Nakayama H, Suzuki K. Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells. Anticancer Res. 2023 Dec;43(12):5377-5386. PMID: 38030198", "BibTeX": "@article{38030198, title={Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells.}, author={Miyazawa Y and Sekine Y and Oka D and Nakazawa S and Tsuji Y and Nakayama H and Suzuki K}, journal={Anticancer Res}, volume={43}, number={12}, pages={5377-5386}}"}}, {"_id": "37910338", "pmid": 37910338, "pmcid": "PMC10620365", "title": "Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer", "journal": "Discov Oncol", "authors": ["Bian Q", "Li B", "Zhang L", "Sun Y", "Zhao Z", "Ding Y", "Yu H"], "date": "2023-11-01T00:00:00Z", "doi": "10.1007/s12672-023-00813-0", "meta_date_publication": "2023 Nov 1", "meta_volume": "14", "meta_issue": "1", "meta_pages": "196", "score": 50262.004, "text_hl": "@CHEMICAL_baicalein @CHEMICAL_MESH:C006680 @@@Baicalein@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_triptolide @CHEMICAL_MESH:C001899 @@@triptolide@@@ and other drugs can effectively inhibit the growth of @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@. ", "citations": {"NLM": "Bian Q, Li B, Zhang L, Sun Y, Zhao Z, Ding Y, Yu H. Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer Discov Oncol. 2023 Nov 1;14(1):196. PMID: 37910338", "BibTeX": "@article{37910338, title={Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer}, author={Bian Q and Li B and Zhang L and Sun Y and Zhao Z and Ding Y and Yu H}, journal={Discov Oncol}, volume={14}, number={1}, pages={196}}"}}, {"_id": "38159995", "pmid": 38159995, "title": "Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression.", "journal": "Anticancer Res", "authors": ["Oka D", "Sekine Y", "Tsuji Y", "Nakayama H", "Miyazawa Y", "Arai S", "Koike H", "Suzuki K"], "date": "2024-01-01T00:00:00Z", "doi": "10.21873/anticanres.16791", "meta_date_publication": "2024 Jan", "meta_volume": "44", "meta_issue": "1", "meta_pages": "93-98", "score": 50258.473, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Enhances the Radiosensitivity of Androgen-independent @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@Prostate Cancer@@@ Cells via Inhibition of @GENE_RAD51 @GENE_5888 @@@RAD51@@@ Expression.", "citations": {"NLM": "Oka D, Sekine Y, Tsuji Y, Nakayama H, Miyazawa Y, Arai S, Koike H, Suzuki K. Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression. Anticancer Res. 2024 Jan;44(1):93-98. PMID: 38159995", "BibTeX": "@article{38159995, title={Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression.}, author={Oka D and Sekine Y and Tsuji Y and Nakayama H and Miyazawa Y and Arai S and Koike H and Suzuki K}, journal={Anticancer Res}, volume={44}, number={1}, pages={93-98}}"}}, {"_id": "35366048", "pmid": 35366048, "pmcid": "PMC9077302", "title": "Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes", "journal": "J Cell Mol Med", "authors": ["Mirzaei A", "Rashedi S", "Akbari MR", "Khatami F", "Aghamir SMK"], "date": "2022-05-01T00:00:00Z", "doi": "10.1111/jcmm.17286", "meta_date_publication": "2022 May", "meta_volume": "26", "meta_issue": "9", "meta_pages": "2728-2740", "score": 50251.98, "text_hl": "Effects of @CHEMICAL_Arsenic_Trioxide @CHEMICAL_MESH:D000077237 @@@ATO@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ on the migration of the @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@ cells", "citations": {"NLM": "Mirzaei A, Rashedi S, Akbari MR, Khatami F, Aghamir SMK. Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes J Cell Mol Med. 2022 May;26(9):2728-2740. PMID: 35366048", "BibTeX": "@article{35366048, title={Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes}, author={Mirzaei A and Rashedi S and Akbari MR and Khatami F and Aghamir SMK}, journal={J Cell Mol Med}, volume={26}, number={9}, pages={2728-2740}}"}}, {"_id": "37287286", "pmid": 37287286, "title": "PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal.", "journal": "Curr Med Chem", "authors": ["Romo-Perez A", "Domínguez-Gómez G", "Chávez-Blanco A", "González-Fierro A", "Correa-Basurto J", "Dueñas-González A"], "date": "2023-06-07T00:00:00Z", "doi": "10.2174/0929867330666230607104441", "meta_date_publication": "2023 Jun 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50249.29, "text_hl": "OBJECTIVE: Based on a literature review, we propose the PaSTe regimen (@CHEMICAL_Pantoprazole @CHEMICAL_MESH:D000077402 @@@Pantoprazole@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@, @CHEMICAL_Trimetazidine @CHEMICAL_MESH:D014292 @@@Trimetazidine@@@) as a metabolic therapy for @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@. ", "citations": {"NLM": "Romo-Perez A, Domínguez-Gómez G, Chávez-Blanco A, González-Fierro A, Correa-Basurto J, Dueñas-González A. PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal. Curr Med Chem. 2023 Jun 7;():. PMID: 37287286", "BibTeX": "@article{37287286, title={PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal.}, author={Romo-Perez A and Domínguez-Gómez G and Chávez-Blanco A and González-Fierro A and Correa-Basurto J and Dueñas-González A}, journal={Curr Med Chem}}"}}, {"_id": "33032653", "pmid": 33032653, "pmcid": "PMC7545949", "title": "Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition", "journal": "J Exp Clin Cancer Res", "authors": ["Iannelli F", "Roca MS", "Lombardi R", "Ciardiello C", "Grumetti L", "De Rienzo S", "Moccia T", "Vitagliano C", "Sorice A", "Costantini S", "Milone MR", "Pucci B", "Leone A", "Di Gennaro E", "Mancini R", "Ciliberto G", "Bruzzese F", "Budillon A"], "date": "2020-10-08T00:00:00Z", "doi": "10.1186/s13046-020-01723-7", "meta_date_publication": "2020 Oct 8", "meta_volume": "39", "meta_issue": "1", "meta_pages": "213", "score": 50248.133, "text_hl": "Synergistic antitumor interaction of @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproic acid@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ sensitizes @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@ to @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@docetaxel@@@ by targeting CSCs compartment via @GENE_YAP1 @GENE_10413 @@@YAP@@@ inhibition", "citations": {"NLM": "Iannelli F, Roca MS, Lombardi R, Ciardiello C, Grumetti L, De Rienzo S, Moccia T, Vitagliano C, Sorice A, Costantini S, Milone MR, Pucci B, Leone A, Di Gennaro E, Mancini R, Ciliberto G, Bruzzese F, Budillon A. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition J Exp Clin Cancer Res. 2020 Oct 8;39(1):213. PMID: 33032653", "BibTeX": "@article{33032653, title={Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition}, author={Iannelli F and Roca MS and Lombardi R and Ciardiello C and Grumetti L and De Rienzo S and Moccia T and Vitagliano C and Sorice A and Costantini S and Milone MR and Pucci B and Leone A and Di Gennaro E and Mancini R and Ciliberto G and Bruzzese F and Budillon A}, journal={J Exp Clin Cancer Res}, volume={39}, number={1}, pages={213}}"}}, {"_id": "38588613", "pmid": 38588613, "title": "Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.", "journal": "Biochem Biophys Res Commun", "authors": ["Göbel A", "Pählig S", "Motz A", "Breining D", "Traikov S", "Hofbauer LC", "Rachner TD"], "date": "2024-05-28T00:00:00Z", "doi": "10.1016/j.bbrc.2024.149841", "meta_date_publication": "2024 May 28", "meta_volume": "710", "meta_issue": "", "meta_pages": "149841", "score": 50243.99, "text_hl": "In our study, we treated @SPECIES_9606 @@@human@@@ @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@ cell lines (@CELLLINE_CVCL:0035 @@@PC3@@@, @CELLLINE_CVCL:4784 @@@C4-2B@@@, @CELLLINE_CVCL:0105 @@@DU-145@@@, @CELLLINE_CVCL:0395 @@@LNCaP@@@) with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@. ", "citations": {"NLM": "Göbel A, Pählig S, Motz A, Breining D, Traikov S, Hofbauer LC, Rachner TD. Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase. Biochem Biophys Res Commun. 2024 May 28;710():149841. PMID: 38588613", "BibTeX": "@article{38588613, title={Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.}, author={Göbel A and Pählig S and Motz A and Breining D and Traikov S and Hofbauer LC and Rachner TD}, journal={Biochem Biophys Res Commun}, volume={710}, pages={149841}}"}}, {"_id": "29950990", "pmid": 29950990, "pmcid": "PMC6008406", "title": "Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair", "journal": "Front Pharmacol", "authors": ["Chen YA", "Shih HW", "Lin YC", "Hsu HY", "Wu TF", "Tsai CH", "Wu CL", "Wu HY", "Hsieh JT", "Tang CH", "Lai CH"], "date": "2018-06-13T00:00:00Z", "doi": "10.3389/fphar.2018.00600", "meta_date_publication": "2018", "meta_volume": "9", "meta_issue": "", "meta_pages": "600", "score": 50084.88, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Sensitizes Radioresistant @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@Prostate Cancer@@@ Cells by Compromising DNA Double-Strand Break Repair", "citations": {"NLM": "Chen YA, Shih HW, Lin YC, Hsu HY, Wu TF, Tsai CH, Wu CL, Wu HY, Hsieh JT, Tang CH, Lai CH. Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair Front Pharmacol. 2018;9():600. PMID: 29950990", "BibTeX": "@article{29950990, title={Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair}, author={Chen YA and Shih HW and Lin YC and Hsu HY and Wu TF and Tsai CH and Wu CL and Wu HY and Hsieh JT and Tang CH and Lai CH}, journal={Front Pharmacol}, volume={9}, pages={600}}"}}]}